Today: 19 May 2026
Browse Category

NASDAQ:HOLX 21 October 2025 - 9 April 2026

Hologic goes private: Blackstone, TPG close buyout and name José Almeida CEO

Hologic goes private: Blackstone, TPG close buyout and name José Almeida CEO

Blackstone and TPG closed their $17.3 billion acquisition of Hologic on April 7, with José Almeida replacing Steve MacMillan as CEO. Hologic shares were suspended before trading that day and will be removed from the S&P 500 before Thursday’s open. Former shareholders will receive $76 per share in cash plus a contingent value right worth up to $3 more if revenue targets are met.
Hologic Buyout Nears Close After Final Approvals in Blackstone-TPG Deal; CEO Steve MacMillan to Retire

Hologic Buyout Nears Close After Final Approvals in Blackstone-TPG Deal; CEO Steve MacMillan to Retire

Hologic said it has secured all regulatory approvals for its $18.3 billion sale to Blackstone and TPG, with closing expected on or about April 7. CEO Steve MacMillan will retire at closing. Nasdaq will halt trading in Hologic shares after Monday’s session and suspend them effective April 8. S&P Dow Jones Indices will remove Hologic from the S&P 500 before the open on April 9.
Hologic CEO Steve MacMillan to Retire as Blackstone, TPG Near $18.3 Billion Buyout Close

Hologic CEO Steve MacMillan to Retire as Blackstone, TPG Near $18.3 Billion Buyout Close

Hologic said CEO Steve MacMillan will retire when its $18.3 billion sale to Blackstone and TPG closes, expected April 7 after all regulatory approvals. Nasdaq plans to halt Hologic shares after trading April 6 and suspend them April 8. Shareholders get $76 per share in cash plus a contingent value right tied to Breast Health revenue targets. The next CEO will be named after the deal closes.
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open

Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open

Hologic closed at $74.50 in a shortened Christmas Eve session, with after-hours trading lifting the stock to $74.80 by 7:00 p.m. ET. The company warned that meeting the 2026 CVR milestone is now more difficult after halting shipments of its Brevera biopsy needles. The stock remains below the $76 cash value in its pending buyout by Blackstone and TPG.
24 December 2025
Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone (BX) Shines With Big Q3 Beat & $18B Hologic Deal – But Why Are Shares Falling?

Blackstone reported Q3 distributable EPS of $1.52, up 48% year-over-year and above estimates, but GAAP EPS fell to $0.80 as revenue dropped 15.7% to $3.09 billion. Shares traded near $160 on Oct. 23, down about 1% intraday and 6% below 2025 highs. Blackstone and TPG agreed to buy Hologic for $18.3 billion, offering a 46% premium. The firm also launched a $5 billion GCC logistics platform with Lunate.
Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone & TPG in $18B Hologic Takeover Shock – Women’s Health Stock Skyrockets

Blackstone and TPG will acquire Hologic for $76 per share in cash plus a contingent value right worth up to $3, valuing the deal at $18.3 billion including debt. Hologic’s board approved the offer, which represents a 46% premium to its pre-deal price. Abu Dhabi Investment Authority and Singapore’s GIC will co-invest. Hologic shares rose about 7% on the news; the deal is expected to close in the first half of 2026.

Stock Market Today

  • Melius Research boosts Intel stock price target to $150 amid market volatility
    May 19, 2026, 4:11 PM EDT. Intel (INTC) shares have fallen 19.17% since their May 11 peak of $129.44, currently trading at $104.62. Despite recent positive news, including Intel's chip manufacturing deals with Apple and expanded partnerships with Google, semiconductor stocks faced pressure due to macro events such as President Trump's China visit without major chip agreements. Melius Research analyst Benjamin Reitzes raised Intel's price target sharply to $150 from $100, signaling a 43.37% upside and maintaining a buy rating. Reitzes, with a 62% success rate, sees strong long-term growth in AI and memory chip segments. However, this target stands out against a consensus average of $87.09 and limited buy recommendations, reflecting market skepticism and Bank of America's bearish stance.

Latest articles

Wall Street Just Got Hit by the Bond Market Again — What Traders Are Watching Next

Wall Street Just Got Hit by the Bond Market Again — What Traders Are Watching Next

19 May 2026
NEW YORK, May 19, 2026, 16:02 (EDT) Wall Street’s main indexes fell on Tuesday, extending a pullback from record highs as Treasury yields — the returns investors demand to hold U.S. government debt — climbed and fed a fresh bout of inflation worry. Shortly after the closing bell, LSEG delayed data on Reuters showed the S&P 500 down 0.55% at 7,362.62, the Nasdaq Composite off 0.72% at 25,903.08 and the Dow Jones Industrial Average down 0.47% at 49,451.19. Brent crude was near $111 a barrel, still high enough to keep investors wary of another inflation shock. (Reuters) That matters now
Intel Stock Bounces as Wall Street Rethinks AI Narrative

Intel Stock Bounces as Wall Street Rethinks AI Narrative

19 May 2026
Intel shares climbed 3.3% to $111.69 Tuesday afternoon, rebounding after five sessions of losses as Citi and Benchmark raised price targets, citing stronger CPU demand. Trading volume topped 112 million shares. The move came ahead of Nvidia’s earnings, which options traders expect to trigger a major market shift. Intel CEO Lip-Bu Tan was set to speak at a J.P. Morgan conference later in the day.
Pinterest shares erase post-earnings gains

Pinterest shares erase post-earnings gains

19 May 2026
Pinterest shares fell about 6% Tuesday, trading at $18.74 by 3:05 p.m. EDT, erasing gains from its May earnings rally. The drop outpaced declines in Meta, Snap, and Reddit as the Nasdaq and S&P 500 also slipped. Pinterest reported Q1 revenue of $1.008 billion, up 18%, with a net loss of $74 million. The company forecast Q2 revenue above analyst expectations.
Go toTop